ALSO READZydus Cadila gets final USFDA nod for hypertension drug Zydus gets audit report of Ahmedabad-based SEZ plant from USFDA Cadila Healthcare says Zydus got USFDA nod to market two drugs Zydus Cadila gets USFDA's final approval to market antidepressant drug Zydus Cadila gets final FDA nod for skin disorder, hypertension drugs
Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market Nifedipine extended release tablets used in treatment of hypertension and chest pain. The company has received the approval from the US Food and Drug Administration (USFDA) to market the drug in the strengths of 30mg, 60mg and 90 mg, Zydus Cadila said in a BSE filing. The company will produce the drug at the group's formulations manufacturing facility at SEZ, Ahmedabad. It has more than 180 approvals and so far filed over 310 abbreviated new drug applications (ANDAs) since it commenced filings in 2003-04.